Elanco Animal Health
ELAN | NYSE
$22.87
+$0.44 (+1.96%)
Sep 22, 2026, 11:01 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.37B | 1.37B | 1.14B | 1.14B | 1.24B | 1.19B | 1.02B | 1.03B | 1.18B | 1.21B | 1.04B | 1.07B | 1.06B | 1.26B | 988M | 1.03B | 1.18B | 1.23B | 1.11B | 1.13B | 1.28B | 1.24B |
Cost of Revenue | 570M | 586M | 694M | 530M | 664M | 637M | 631M | 625M | 626M | 648M | 654M | 627M | 570M | 628M | 578M | 600M | 617M | 646M | 651M | 643M | 680M | 716M |
Gross Profit | 798M | 785M | 450M | 607M | 577M | 556M | 389M | 405M | 558M | 557M | 381M | 441M | 487M | 629M | 410M | 426M | 558M | 580M | 462M | 488M | 599M | 526M |
Operating Income | 109M | 307M | 19M | 27M | 85M | 121M | 8M | -5M | 115M | 133M | 10M | 42M | 53M | 221M | 27M | 50M | 133M | 176M | 43M | 52M | 120M | 89M |
Interest Income | n/a | n/a | 11M | n/a | 11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 56M | 87M | -259M | -50M | 25M | 60M | -51M | 559M | -32M | 12M | -127M | -1.1B | -79M | 108M | -88M | -44M | -14M | 75M | -119M | -130M | -236M | -80M |
Net Income | 54M | 57M | -276M | -34M | 11M | 67M | -8M | 364M | -50M | 32M | -141M | -1.1B | -97M | 103M | -54M | -65M | -10M | 51M | -104M | -104M | -210M | -61M |
Selling & General & Admin | 449M | 381M | 338M | 351M | 400M | 341M | 300M | 323M | 354M | 337M | 292M | 313M | 353M | 327M | 303M | 298M | 343M | 323M | 327M | 342M | 385M | 348M |
Research & Development | 92M | 97M | 93M | 89M | 92M | 94M | 81M | 87M | 89M | 87M | 79M | 86M | 81M | 81M | 80M | 78M | 82M | 81M | 92M | 94M | 94M | 89M |
Other Expenses | 148M | n/a | n/a | 140M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 689M | 478M | 431M | 580M | 492M | 435M | 381M | 410M | 443M | 424M | 371M | 399M | 434M | 408M | 383M | 376M | 425M | 404M | 419M | 436M | 479M | 437M |
Interest Expense | 59M | 57M | 91M | 52M | 70M | 53M | 62M | 85M | 65M | 66M | 67M | 72M | 103M | 68M | 65M | 60M | 68M | 55M | 83M | 60M | 67M | 179M |
Selling & Marketing Expenses | 449M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.26B | 1.06B | 1.13B | 1.11B | 1.16B | 1.07B | 1.01B | 1.04B | 1.07B | 1.07B | 1.03B | 1.03B | 1B | 1.04B | 961M | 976M | 1.04B | 1.05B | 1.07B | 1.08B | 1.16B | 1.15B |
Income Tax Expense | 2M | 30M | 17M | -16M | 14M | -7M | -43M | 195M | 18M | -20M | 14M | -1M | 18M | 5M | -34M | 21M | -4M | 24M | -15M | -26M | -26M | -19M |
Shares Outstanding (Basic) | 499.5M | 497.7M | 496.9M | 496.8M | 496.6M | 495.1M | 494.4M | 494.3M | 494.2M | 493.2M | 492.8M | 492.7M | 492.6M | 491.1M | 488.5M | 488.4M | 488.4M | 488M | 487.4M | 487.3M | 487.3M | 486.7M |
Shares Outstanding (Diluted) | 505.9M | 506M | 496.9M | 496.8M | 500.1M | 499.1M | 494.4M | 497.7M | 494.2M | 496M | 492.8M | 492.7M | 492.6M | 492.8M | 488.5M | 488.4M | 488.4M | 492.2M | 487.4M | 487.3M | 487.3M | 486.7M |
EPS (Basic) | 0.11 | 0.11 | -0.56 | -0.07 | 0.02 | 0.14 | -0.02 | 0.74 | -0.10 | 0.06 | -0.29 | -2.22 | -0.20 | 0.21 | -0.11 | -0.13 | -0.02 | 0.10 | -0.20 | -0.21 | -0.43 | -0.13 |
EPS (Diluted) | 0.11 | 0.11 | -0.55 | -0.07 | 0.02 | 0.13 | -0.02 | 0.73 | -0.10 | 0.06 | -0.29 | -2.22 | -0.20 | 0.21 | -0.11 | -0.13 | -0.02 | 0.10 | -0.20 | -0.21 | -0.43 | -0.13 |
EBITDA | 274M | 316M | 6M | 178M | 264M | 274M | 175M | 814M | 195M | 244M | 111M | -852M | 201M | 349M | 146M | 183M | 225M | 306M | 138M | 100M | 1M | 301M |
EBIT | 103M | 144M | -168M | 2M | 95M | 113M | 11M | 644M | 33M | 78M | -60M | -1.03B | 24M | 176M | -23M | 16M | 54M | 130M | -36M | -70M | -169M | 99M |
Depreciation & Amortization | 171M | 172M | 174M | 176M | 169M | 161M | 164M | 170M | 162M | 166M | 171M | 173M | 177M | 173M | 169M | 167M | 171M | 176M | 174M | 170M | 170M | 202M |
Add to Watchlist
Select watchlists to add or remove ELAN